Blood glucose monitoring refers to the regular measurement of glucose levels in the blood. This monitoring is required for diabetics to effectively manage their disease. Individuals who measure their blood glucose levels can make more educated decisions about their diet, exercise, and medication to keep their blood sugar in a healthy range. Blood glucose levels can be measured with a variety of devices, including glucose meters, continuous glucose monitoring systems, and wearables.
According to SPER Market Research, ‘Japan Blood Glucose Monitoring Market Size- By Type, By Component - Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ states that The Japan Blood Glucose Monitoring Market is estimated to reach USD 1.6 billion by 2033 with a CAGR of 7.25%.
Drivers: The increasing prevalence of diabetes in Japan is pushing the market for blood glucose devices in a variety of ways. For instance, as diabetes grows more frequent, there is a greater demand for blood glucose monitoring devices among individuals suffering from the condition. This has resulted in increased adoption of these devices, increasing market growth. Second, the Japanese government has actively pushed diabetes treatment and prevention programs, which has aided market growth. These programs usually emphasize the importance of regular blood glucose monitoring, which raises awareness and demand for blood glucose monitors.
Download sample PDF copy of this report to understand structure of the complete report @ https://www.sperresearch.com/report-store/japan-blood-glucose-monitoring-market.aspx?sample=1
Challenges:
Procedures for Approval and Regulatory Barriers - Approval processes and regulatory constraints present numerous challenges for the Japanese glucose monitoring device market. Strict regulations apply to medical devices in Japan, especially glucose monitoring devices. These devices need to be approved by the Pharmaceuticals and Medical Devices Agency (PMDA) after undergoing extensive testing. Because they usually require extensive documentation, clinical testing, and adherence to specific standards, these regulatory processes can be costly and time-consuming for producers.
COVID-19 Impact: The COVID-19 epidemic has had a major effect on the blood glucose monitoring industry in Japan. Remote monitoring became more important as a result of the outbreak, which also reduced in-person medical appointments. In order to safely manage their condition, people with diabetes—who are believed to be more susceptible to severe COVID-19 complications—are increasingly turning to telemedicine and home-based blood glucose monitoring. The epidemic also brought attention to the shortcomings of healthcare systems, emphasizing the need for efficient diabetes treatment programs. Governments and healthcare organizations focused on enhancing the infrastructure for diabetes care, particularly access to blood glucose monitoring equipment, in order to reduce the risk of complications and improve overall patient outcomes.
The market for blood glucose monitoring in Japan is dominated by the Kanto Region. Being the most populated area, it includes Tokyo and other large cities, which have higher prevalence of diabetes because of their advanced healthcare systems, larger senior population, and lifestyle choices. Some of the key players in the market are Abbott Diabetes Care, Roche Holding AG, LifeScan, Dexcom Inc, Medtronic PLC, Arkray Inc, and others.
Japan Blood Glucose Monitoring Market Segmentation:
By Type: Based on the Type, Japan Blood Glucose Monitoring Market is segmented as; Self-Monitoring Blood Glucose, And Continuous Glucose Monitoring.
By Component: Based on the Component, Japan Blood Glucose Monitoring Market is segmented as; Glucometer Devices, Test Strips, Lancets, Sensors, And Durables.
By Region: This research includes data for Kanto Region, Kniki Region, Central/Chubu Region, Kyushu-Okinawa Region, Chugoku Region and Shikoku Region.
For More Information in Japan Blood Glucose Monitoring Market, refer to below link –
Others Industry Report –
Follow Us –
Contact Us:
Sara Lopes, Business Consultant – U.S.A.
SPER Market Research
+1-347-460-2899
Comments